产品质量 & 安全

Our pharmacovigilance and 患者安全 teams identify potential safety issues and mitigate their impact on patients in order to improve the patient experience.

在2022年期间, 在任何给定时间, these teams were supporting approximately 250 clinical trials and approximately 200 marketed products and devices.

These teams also address any risks of our medicines being counterfeited or diverted by regularly providing education and training to employees, health care providers and law enforcement officials in higher-risk geographies.

We have robust systems in place to ensure the products we manufacture are high quality and available when customers and patients need them. Our Quality Council oversees our quality strategy and is accountable directly to our CEO. Expert teams oversee every aspect of our processes, from discovery and development through manufacturing and delivery.

除了内部控制措施, 我们的质量过程进行了审查, certified and audited by multiple external regulatory authorities and notified parties. We use an integrated enterprise quality management system that complies with all applicable global standards and regulations (GxP) from the U.S. 食物 & Drug Administration (FDA), 欧洲an Medicines Agency (EMA) and other leading standards organizations.

Our assurance of supply program is designed to help us maintain supply of medicines and products. We ensure patients and customers continue to receive uninterrupted supply of the products they need, 即使在不可预知的情况下, by identifying and qualifying backup suppliers, scanning the environment for potential risks and doing scenario planning.

To ensure the quality and integrity of our supply chain, we have a 供应链管理系统 that includes criticality assessment, controls, relationship management and continuous monitoring.

AbbVie's supply chain is consistently ranked as a global supply chain leader, 2022年, was ranked #20 in the Gartner Supply Chain Top 25.